Cannabinoids are chemical compounds that are found in the cannabis plant. There are more than 100 different cannabinoids that we know of, among them being the most well-known, THC (tetrahydrocannabinol) and CBD (cannabidiol). THC is the compound that is responsible for the psychoactive effects of cannabis and the hype surrounding both negative and positive media coverage, while CBD affects more of a somatic response that is preferred for medicinal use and doesn't really make the headlines much.
Cannabis plants can be of either indica or sativa speciates, while there are even rare species known as ruderalis. Ruderalis is not often grown for human ingestion and is more often grown for fiber. Indica plants are shorter and bushier and native to moderate climates, while sativa plants are taller and thinner and native to more arid and hot climes. THC and CBD levels can vary depending on the plant type and the breeding history. Cannabis that is high in THC is often used for recreational purposes and is bred as such, while cannabis that is high in CBD is often used for medical purposes. While both cannabinoids have their pros and cons, true medicinal value comes from what is termed the "entourage effect" where CBD is made more effective with an accompanying micro-dose of THC.
The effects of cannabinoids on the human body are largely dependent on which cannabinoid is involved. THC is known to cause psychoactive effects, while CBD is known to have several medical benefits. Some of the medical benefits of CBD include reducing anxiety, relieving pain, and reducing inflammation. THC is known to have an anti-depressant effect with an energetic and focusing factor to it.
 Delta-8 THC is another cannabinoid that is gaining popularity due to its similar effects to THC, but with less psychoactive effects. Hemp plants are a type of cannabis plant that contain high levels of CBD and low levels of THC. CBG (cannabigerol) is another cannabinoid that is starting to gain more attention due to its potential medical benefits.
Leave Comment Below
0 Comment(s)